While one of the key objectives is to raise sales from the investment made, the other is to sow seeds for future growth through the following: Debottlenecking and expanding existing products and product groups Growing downstream and upstream products Entering related products and product groups Introducing retail products and formulations Pursuing unrelated products, product groups and businesses (in a small way) As of now, our Company is executing RoI projects of ` 243 cr and non-RoI projects of ` 206 cr (warehouse, other infrastructure, etc). Atul Foundation received ` 15 cr from our Company, its subsidiary, JV and associate entities and ` 14 cr from the Government, corporates and individuals. Commenced GMDC Atul Vidyalaya School in Kadipani, Chhotaudepur Conducted 63 eye camps, covering 19,531 patients Facilitated 28,308 people to access 20 schemes of the Government We continue to nurture the spirit of social service as our Company grows its businesses. Please visit www.atulfoundation.org to know more. Our Company has a work environment where people are valued and team members are professionally challenged to give their best. We are focusing on the following: Developing team members (for higher and wider responsibilities) Enhancing performance focus Recruiting young talent and recruiting right Strengthening leadership pipeline in higher management Upgrading and digitalising HR processes Our Company has people of diverse nationalities – American, Brazilian, Chinese, English, Nepalese and of course Indian – working cohesively and learning together. There were changes in the Board to remain in sync with the mandate from the Companies Act 2013 and Securities and Exchange Board of India: Mr Mukund Chitale, Ms Shubhalakshmi Panse and Mr Baldev Arora retired as Independent Directors (IDs) after completing 10 years each. On behalf of the Board and my colleagues, I thank Mr Chitale, Ms Panse and Mr Arora for their critical analysis, constructive approach and constant encouragement. Ms Padmaja Chunduru, former Chairperson of Indian Bank and Managing Director and CEO of National Securities and Depository joined the Board as an ID. On behalf of the Board, I welcome Ms Chunduru. We are proposing to add two more IDs with commercial and techno- commercial insights. Mr Vivek Gadre, President, Corporate Strategy, was appointed as a Whole-time Director to succeed Mr Bharathy Mohanan, Whole-time Director, who retires on May 25, 2025. In order to maintain continuity and further strengthen the management, we are also planning to induct two more Executive Directors on the Board. We have further enhanced this second integrated annual report and hope it will help you to understand how we are developing our Company. ESG action reporting Risk management reporting Existing content restructuring Our Company received ICAI award for Excellence in Financial Reporting 2023-24 (Manufacturing and Trading Sector). We are grateful to all our stakeholders: Customers – for pushing us to innovate and improve every day Employees – for making our workplace diverse and dynamic Society – for offering us an opportunity to serve Shareholders – for supporting our efforts to create value We are here to give back more than we take. Our dreams are surging bigger and better – We will work relentlessly to build capability and enhance performance as we enter 2025-26 and beyond. We will co-create our vision and strategy responsibly We will prioritise long-term value as against short-term gains We will balance financial and social returns Our purpose and Values will guide us as we continue our path into the future, convinced that chemistry is vital and is connected with almost anything. Sincerely, Sunil Siddharth Lalbhai Chairman and Managing Director There are three ways to solve a problem. First – the bad way – is when we think we solved the problem but actually we have only shifted it. Two – still the bad way – is when we think we solved the problem but actually we have deepened it. And three – the better way – is when we have not only solved the problem but also solved a class of problems. Our endeavour is to solve the problem the better way. Valsad Insititute of Medical Sciences Statutory Reports Financial Statements 15 Corporate overview Performance overview ESG overview
RkJQdWJsaXNoZXIy MjA2MDI2